Status:
COMPLETED
Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
Lead Sponsor:
Rabin Medical Center
Conditions:
Bronchoscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Passing a bronchoscope through the airways frequently causes a stress response even though patients are sedated. This stress response is usually an increase in pulse and blood pressure, which may have...
Eligibility Criteria
Inclusion
- All patients over 18 years old undergo fiberoptic bronchoscopy in our unit
Exclusion
- inability or refusal to give informed consent
- bronchoscopy through an artificial airway
- intolerance or allergy to the study drug
- bradycardia (HR\<60/min) or hypotension (systolic BP \<100) at screening
- pregnancy,
- concomitant treatment with diltiazem or verapamil
- intention to use propofol as the sedative agent for bronchoscopy.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00394537
End Date
May 1 2007
Last Update
June 6 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49100